Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Classificação em ações
#4335
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Preço da ação
$3.87
Valor de mercado
$3.57B
Variação (1 dia)
-1.64%
Variação (1 ano)
9.08%
País
CN
Negociar Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Categoria
Healthcare
Lucros da Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Hubei Jumpcan Pharmaceutical Co., Ltd., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Hubei Jumpcan Pharmaceutical Co., Ltd. de 2001 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| 2025 | $309.05M | -24.26% |
| 2024 | $408.03M | -12.40% |
| 2023 | $465.78M | 28.11% |
| 2022 | $363.58M | 18.48% |
| 2021 | $306.87M | 35.13% |
| 2020 | $227.09M | -16.47% |
| 2019 | $271.87M | -5.40% |
| 2018 | $287.38M | 30.25% |
| 2017 | $220.64M | 40.80% |
| 2016 | $156.70M | 27.27% |
| 2015 | $123.13M | 26.13% |
| 2014 | $97.62M | 27.38% |
| 2013 | $76.64M | 66.50% |
| 2012 | $46.03M | 3,404.74% |
| 2011 | $1.31M | -0.73% |
| 2010 | $1.32M | 15.79% |
| 2009 | $1.14M | -13.96% |
| 2008 | $1.33M | -42.34% |
| 2007 | $2.30M | 28.76% |
| 2006 | $1.79M | 27.84% |
| 2005 | $1.40M | 13.48% |
| 2004 | $1.23M | -0.48% |
| 2003 | $1.24M | -50.58% |
| 2002 | $2.51M | -0.21% |
| 2001 | $2.51M | 0.00% |
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
